The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Famciclovir Market Research Report 2024
Synopsis
Famciclovir is an antiviral drug. It slows the growth and spread of the herpes virus so that the body can fight off the infection. Famciclovir will not cure herpes, but it can lessen the symptoms of the infections.
The global Famciclovir market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Famciclovir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Famciclovir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Famciclovir include Novartis, Mylan, Teva, Cipla, Hikma, Apotex, Aurobindo Pharma, Macleods Pharmaceuticals and Beijing Jialin Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Famciclovir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Famciclovir.
Report Scope
The Famciclovir market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Famciclovir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Famciclovir manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Mylan
Teva
Cipla
Hikma
Apotex
Aurobindo Pharma
Macleods Pharmaceuticals
Beijing Jialin Pharmaceutical
HETERO
Hainan choitec Pharmaceuticals
Shandong Luoxin Pharmaceutical Group
Chengdu Diao Pharmaceutical Group
HISUN
Segment by Type
125 mg Tablets
250 mg Tablets
500 mg Tablets
Segment by Application
Cold Sores
Genital Herpes
Shingles
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Famciclovir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Famciclovir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Famciclovir is an antiviral drug. It slows the growth and spread of the herpes virus so that the body can fight off the infection. Famciclovir will not cure herpes, but it can lessen the symptoms of the infections.
The global Famciclovir market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Famciclovir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Famciclovir is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Famciclovir include Novartis, Mylan, Teva, Cipla, Hikma, Apotex, Aurobindo Pharma, Macleods Pharmaceuticals and Beijing Jialin Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Famciclovir, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Famciclovir.
Report Scope
The Famciclovir market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Famciclovir market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Famciclovir manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Novartis
Mylan
Teva
Cipla
Hikma
Apotex
Aurobindo Pharma
Macleods Pharmaceuticals
Beijing Jialin Pharmaceutical
HETERO
Hainan choitec Pharmaceuticals
Shandong Luoxin Pharmaceutical Group
Chengdu Diao Pharmaceutical Group
HISUN
Segment by Type
125 mg Tablets
250 mg Tablets
500 mg Tablets
Segment by Application
Cold Sores
Genital Herpes
Shingles
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Famciclovir manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Famciclovir in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Famciclovir Market Overview
1.1 Product Overview and Scope of Famciclovir
1.2 Famciclovir Segment by Type
1.2.1 Global Famciclovir Market Value Comparison by Type (2024-2030)
1.2.2 125 mg Tablets
1.2.3 250 mg Tablets
1.2.4 500 mg Tablets
1.3 Famciclovir Segment by Application
1.3.1 Global Famciclovir Market Value by Application: (2024-2030)
1.3.2 Cold Sores
1.3.3 Genital Herpes
1.3.4 Shingles
1.4 Global Famciclovir Market Size Estimates and Forecasts
1.4.1 Global Famciclovir Revenue 2019-2030
1.4.2 Global Famciclovir Sales 2019-2030
1.4.3 Global Famciclovir Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Famciclovir Market Competition by Manufacturers
2.1 Global Famciclovir Sales Market Share by Manufacturers (2019-2024)
2.2 Global Famciclovir Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Famciclovir Average Price by Manufacturers (2019-2024)
2.4 Global Famciclovir Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Famciclovir, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Famciclovir, Product Type & Application
2.7 Famciclovir Market Competitive Situation and Trends
2.7.1 Famciclovir Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Famciclovir Players Market Share by Revenue
2.7.3 Global Famciclovir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Famciclovir Retrospective Market Scenario by Region
3.1 Global Famciclovir Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Famciclovir Global Famciclovir Sales by Region: 2019-2030
3.2.1 Global Famciclovir Sales by Region: 2019-2024
3.2.2 Global Famciclovir Sales by Region: 2025-2030
3.3 Global Famciclovir Global Famciclovir Revenue by Region: 2019-2030
3.3.1 Global Famciclovir Revenue by Region: 2019-2024
3.3.2 Global Famciclovir Revenue by Region: 2025-2030
3.4 North America Famciclovir Market Facts & Figures by Country
3.4.1 North America Famciclovir Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Famciclovir Sales by Country (2019-2030)
3.4.3 North America Famciclovir Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Famciclovir Market Facts & Figures by Country
3.5.1 Europe Famciclovir Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Famciclovir Sales by Country (2019-2030)
3.5.3 Europe Famciclovir Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Famciclovir Market Facts & Figures by Country
3.6.1 Asia Pacific Famciclovir Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Famciclovir Sales by Country (2019-2030)
3.6.3 Asia Pacific Famciclovir Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Famciclovir Market Facts & Figures by Country
3.7.1 Latin America Famciclovir Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Famciclovir Sales by Country (2019-2030)
3.7.3 Latin America Famciclovir Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Famciclovir Market Facts & Figures by Country
3.8.1 Middle East and Africa Famciclovir Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Famciclovir Sales by Country (2019-2030)
3.8.3 Middle East and Africa Famciclovir Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Famciclovir Sales by Type (2019-2030)
4.1.1 Global Famciclovir Sales by Type (2019-2024)
4.1.2 Global Famciclovir Sales by Type (2025-2030)
4.1.3 Global Famciclovir Sales Market Share by Type (2019-2030)
4.2 Global Famciclovir Revenue by Type (2019-2030)
4.2.1 Global Famciclovir Revenue by Type (2019-2024)
4.2.2 Global Famciclovir Revenue by Type (2025-2030)
4.2.3 Global Famciclovir Revenue Market Share by Type (2019-2030)
4.3 Global Famciclovir Price by Type (2019-2030)
5 Segment by Application
5.1 Global Famciclovir Sales by Application (2019-2030)
5.1.1 Global Famciclovir Sales by Application (2019-2024)
5.1.2 Global Famciclovir Sales by Application (2025-2030)
5.1.3 Global Famciclovir Sales Market Share by Application (2019-2030)
5.2 Global Famciclovir Revenue by Application (2019-2030)
5.2.1 Global Famciclovir Revenue by Application (2019-2024)
5.2.2 Global Famciclovir Revenue by Application (2025-2030)
5.2.3 Global Famciclovir Revenue Market Share by Application (2019-2030)
5.3 Global Famciclovir Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Famciclovir Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Corporation Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mylan Famciclovir Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva Famciclovir Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Cipla
6.4.1 Cipla Corporation Information
6.4.2 Cipla Description and Business Overview
6.4.3 Cipla Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cipla Famciclovir Product Portfolio
6.4.5 Cipla Recent Developments/Updates
6.5 Hikma
6.5.1 Hikma Corporation Information
6.5.2 Hikma Description and Business Overview
6.5.3 Hikma Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Hikma Famciclovir Product Portfolio
6.5.5 Hikma Recent Developments/Updates
6.6 Apotex
6.6.1 Apotex Corporation Information
6.6.2 Apotex Description and Business Overview
6.6.3 Apotex Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Apotex Famciclovir Product Portfolio
6.6.5 Apotex Recent Developments/Updates
6.7 Aurobindo Pharma
6.6.1 Aurobindo Pharma Corporation Information
6.6.2 Aurobindo Pharma Description and Business Overview
6.6.3 Aurobindo Pharma Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Aurobindo Pharma Famciclovir Product Portfolio
6.7.5 Aurobindo Pharma Recent Developments/Updates
6.8 Macleods Pharmaceuticals
6.8.1 Macleods Pharmaceuticals Corporation Information
6.8.2 Macleods Pharmaceuticals Description and Business Overview
6.8.3 Macleods Pharmaceuticals Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Macleods Pharmaceuticals Famciclovir Product Portfolio
6.8.5 Macleods Pharmaceuticals Recent Developments/Updates
6.9 Beijing Jialin Pharmaceutical
6.9.1 Beijing Jialin Pharmaceutical Corporation Information
6.9.2 Beijing Jialin Pharmaceutical Description and Business Overview
6.9.3 Beijing Jialin Pharmaceutical Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Beijing Jialin Pharmaceutical Famciclovir Product Portfolio
6.9.5 Beijing Jialin Pharmaceutical Recent Developments/Updates
6.10 HETERO
6.10.1 HETERO Corporation Information
6.10.2 HETERO Description and Business Overview
6.10.3 HETERO Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.10.4 HETERO Famciclovir Product Portfolio
6.10.5 HETERO Recent Developments/Updates
6.11 Hainan choitec Pharmaceuticals
6.11.1 Hainan choitec Pharmaceuticals Corporation Information
6.11.2 Hainan choitec Pharmaceuticals Famciclovir Description and Business Overview
6.11.3 Hainan choitec Pharmaceuticals Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Hainan choitec Pharmaceuticals Famciclovir Product Portfolio
6.11.5 Hainan choitec Pharmaceuticals Recent Developments/Updates
6.12 Shandong Luoxin Pharmaceutical Group
6.12.1 Shandong Luoxin Pharmaceutical Group Corporation Information
6.12.2 Shandong Luoxin Pharmaceutical Group Famciclovir Description and Business Overview
6.12.3 Shandong Luoxin Pharmaceutical Group Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Shandong Luoxin Pharmaceutical Group Famciclovir Product Portfolio
6.12.5 Shandong Luoxin Pharmaceutical Group Recent Developments/Updates
6.13 Chengdu Diao Pharmaceutical Group
6.13.1 Chengdu Diao Pharmaceutical Group Corporation Information
6.13.2 Chengdu Diao Pharmaceutical Group Famciclovir Description and Business Overview
6.13.3 Chengdu Diao Pharmaceutical Group Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Chengdu Diao Pharmaceutical Group Famciclovir Product Portfolio
6.13.5 Chengdu Diao Pharmaceutical Group Recent Developments/Updates
6.14 HISUN
6.14.1 HISUN Corporation Information
6.14.2 HISUN Famciclovir Description and Business Overview
6.14.3 HISUN Famciclovir Sales, Revenue and Gross Margin (2019-2024)
6.14.4 HISUN Famciclovir Product Portfolio
6.14.5 HISUN Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Famciclovir Industry Chain Analysis
7.2 Famciclovir Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Famciclovir Production Mode & Process
7.4 Famciclovir Sales and Marketing
7.4.1 Famciclovir Sales Channels
7.4.2 Famciclovir Distributors
7.5 Famciclovir Customers
8 Famciclovir Market Dynamics
8.1 Famciclovir Industry Trends
8.2 Famciclovir Market Drivers
8.3 Famciclovir Market Challenges
8.4 Famciclovir Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
